Improving urban bicycle infrastructure-an exploratory study based on the effects from the COVID-19 Lockdown

por Schwarz, Lucas, Keler, Andreas, Krisp, Jukka M.
Publicado 2022

Pairwise correlation graphs from hippocampal population activity have highly non-random, low-dimensional clique topology

por Curto, Carina, Giusti, Chad, Marku, Keler, Pastalkova, Eva, Itskov, Vladimir
Publicado 2013

Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity

por Thomas, Lawrence J, He, Li-Zhen, Marsh, Henry, Keler, Tibor
Publicado 2014

Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine

por He, Li-Zhen, Weidlick, Jeffrey, Sisson, Crystal, Marsh, Henry C, Keler, Tibor
Publicado 2015

Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab

por Ramakrishna, Venky, Sundarapandiyan, Karuna, Zhao, Biwei, Bylesjo, Max, Marsh, Henry C., Keler, Tibor
Publicado 2015

Strong association of mast cells with eosinophilic esophagitis‐specific signatures

por Alvarado, Diego, Lu, Yufang, Shoda, Tetsuo, Caldwell, Julie M., Keler, Tibor, Rothenberg, Marc E.
Publicado 2022

Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells

por Ramakrishna, Venky, Vasilakos, John P, Tario, Joseph D, Berger, Marc A, Wallace, Paul K, Keler, Tibor
Publicado 2007

Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice

por Wang, Bei, Zaidi, Neeha, He, Li-Zhen, Zhang, Li, Kuroiwa, Janelle MY, Keler, Tibor, Steinman, Ralph M
Publicado 2012

Converting tumors into vaccine manufacturing factories: DC recruitment, activation and clinical responses with a flt3L-primed in situ vaccine for low-grade lymphoma [nct01976585]

por Bhardwaj, Nina, Merad, Miriam, Kim-Schulze, Seunghee, Crowley, Beth, Davis, Thomas, Keler, Tibor, Salazar, Andres, Brody, Joshua
Publicado 2014

Overcoming primary and acquired resistance to anti-PD-L1 therapy by induction and activation of tumor-residing cDC1s

por Oba, Takaaki, Long, Mark D., Keler, Tibor, Marsh, Henry C., Minderman, Hans, Abrams, Scott I., Liu, Song, Ito, Fumito
Publicado 2020

Combination therapies augment the anti-tumor activity of agonist CD27 mAb in human CD27 transgenic mouse models

por He, Li-Zhen, Thomas, Lawrence J, Testa, James, Weidlick, Jeffrey, Sisson, Crystal, Hammond, Russell, Vitale, Laura, Marsh, Henry, Keler, Tibor
Publicado 2013

Conditioning treatment with CD27 Ab enhances expansion and antitumor activity of adoptively transferred T cells in mice

por Wasiuk, Anna, Weidlick, Jeff, Sisson, Crystal, Widger, Jenifer, Crocker, Andrea, Vitale, Laura, Marsh, Henry C., Keler, Tibor, He, Li-Zhen
Publicado 2021

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

por Burris, Howard, Ansell, Stephen, Neumanitis, John, Weiss, Geoffrey, Sikic, Branimir, Northfelt, Donald, Pilja, Lana, Davis, Thomas, Yellin, Michael, Keler, Tibor, Bullock, Timothy
Publicado 2013

A phase I study of an agonist anti-CD27 human antibody (CDX-1127) in patients with advanced hematologic malignancies or solid tumors

por Ansell, Stephen, Northfelt, Donald, Flinn, Ian, Burris, Howard, Dinner, Shira, Villalobos, Victor, Sikic, Branimir, Pilja, Lana, Yellin, Michael, Keler, Tibor, Davis, Thomas
Publicado 2013

Immune correlates of Varlilumab treated cancer patients are consistent with CD27 costimulatory activity

por Bullock, Timothy, McClintic, Hillary, Jeong, Se, Smith, Kelly, Olson, Walt, Ramakrishna, Venky, Vitale, Laura, Green, Jennifer, Yellin, Michael, Davis, Thomas, Keler, Tibor
Publicado 2014

Circulating precursors of human CD1c(+) and CD141(+) dendritic cells

por Breton, Gaëlle, Lee, Jaeyop, Zhou, Yu Jerry, Schreiber, Joseph J., Keler, Tibor, Puhr, Sarah, Anandasabapathy, Niroshana, Schlesinger, Sarah, Caskey, Marina, Liu, Kang, Nussenzweig, Michel C.
Publicado 2015

The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent

por He, Li-Zhen, Wasiuk, Anna, Testa, James, Weidlick, Jeffrey, Sisson, Crsytal, Crocker, Andrea, Widger, Jenifer, Forsberg, Eirc, Gergel, Lauren, Thomas, Lawrence, Marsh, Henry, Keler, Tibor
Publicado 2015

Antigen delivery to early endosomes eliminates the superiority of human blood BDCA3(+) dendritic cells at cross presentation

por Cohn, Lillian, Chatterjee, Bithi, Esselborn, Filipp, Smed-Sörensen, Anna, Nakamura, Norihiro, Chalouni, Cécile, Lee, Byoung-Chul, Vandlen, Richard, Keler, Tibor, Lauer, Peter, Brockstedt, Dirk, Mellman, Ira, Delamarre, Lélia
Publicado 2013

A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade i...

por McGray, A. J. R., Eppolito, C., Miliotto, A., Singel, K. L., Stephenson, K., Lugade, A., Segal, B. H., Keler, T., Webster, G., Lichty, B., Kozbor, D., Odunsi, K.
Publicado 2021

Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent

por Marquez-Nostra, Bernadette V., Lee, Supum, Laforest, Richard, Vitale, Laura, Nie, Xingyu, Hyrc, Krzysztof, Keler, Tibor, Hawthorne, Thomas, Hoog, Jeremy, Li, Shunqiang, Dehdashti, Farrokh, Ma, Cynthia X., Lapi, Suzanne E.
Publicado 2017